Skip to Main Content
An official website of the United States government
Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, February 7th from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime.

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
141-160 of 1488
Name Principal Investigator Institution Study Date Approved Project ID
A Twin SQL and Smart Cancer Repository and Query System with Analytical Intelligence Capability and Shared Access Nezamoddin Nezamoddini-Kachouie Florida Institute of Technology PLCO Jul 24, 2024 PLCO-1633
Biological Variability in Ovarian Cancer Incidence and Severity Mariah Malak Bilalaga MedStar Union Memorial Hospital PLCO Jul 22, 2024 PLCO-1630
Associations between vitamin D-related genotypes and prostate and colorectal cancer risk and survival by race/ethnicity in PLCO Demetrius Albanes National Cancer Institute PLCO Jul 22, 2024 PLCO-1626
Analyzing PSA-based Prostate Cancer Screening using Causal Inference Methods Robert Tibshirani Leland Stanford Junior University PLCO Jul 22, 2024 PLCO-1625
TransparentAI: High-Accuracy and Explainable Melanoma Classification System Björn Friedrich Carl von Ossietzky University, Medicine and Health Sciences, Department of Health Services Research, Division for Assistance Systems and Medical Device Technology PLCO Jul 15, 2024 PLCO-1623
The Impact of Obesity on the Diagnosis and Treatment of Colorectal Cancer Jaime Savitz Keck Graduate Institute (KGI) PLCO Jul 15, 2024 PLCO-1618
Advancing Precision Oncology Through Digital Profiling: Integrating Multimodal Data for Personalized Cancer Treatment Abdul Azeez Irfan Sri Lanka Institute of Information Technology PLCO Jul 8, 2024 PLCO-1579
Detecting possible individuals with benefit from ovarian cancer screening: a counterfactual prediction modelling study David van Klaveren Erasmus University Medical Center PLCO Jul 8, 2024 PLCO-1606
Structural nature of time-related biases in cancer screening studies: Using PLCO Trial data to inform causal diagrams and simulation Matthew Coates University of California, Los Angeles PLCO Jul 8, 2024 PLCO-1615
Biomarkers for Head and Neck Cancer Uday Kumbhar Innotech Precision Medicine PLCO Jul 8, 2024 PLCO-1571
An interdisciplinary approach to investigate factors influencing the changes in age-specific incidence of ovarian cancer. Imogen Rogers University of Sussex PLCO Jul 8, 2024 PLCO-1605
Development and validation of risk prediction models for lung cancer for the ENGAGE framework Iakovos Toumazis The University of Texas MD Anderson Cancer Center PLCO Jun 24, 2024 PLCO-1603
Using population-based healthcare data to investigate the risk of mortality or relapse after radiotherapy for prostate cancer Bill Nailon University of Edinburgh PLCO Jun 24, 2024 PLCO-1601
Genetics of prostate cancer survival in African-American men Robert Klein Icahn School of Medicine at Mount Sinai PLCO Jun 17, 2024 2024-0110
The interaction between sex and germline genetics on the risk of pancreatic cancer Barbara Stranger Northwestern University PLCO Jun 17, 2024 PLCO-1589
Association of a poly-metabolite score for ultra-processed food intake and breast cancer risk Leila Abar National Cancer Institute PLCO Jun 17, 2024 PLCO-1596
AI-driven Analysis of Risk Factors in Lung Cancer Development Antonio Jesus Diaz Honrubia Universidad Politécnica de Madrid PLCO Jun 17, 2024 PLCO-1593
Developing polygenic risk models for complex traits and diseases Jianxin Shi NCI PLCO Jun 7, 2024 PLCO-1577
Develop an end-to-end LLM-powered application tailored for precise care of cancer patients with advance features Ananya Singh Indian Institute of Technology PLCO Jun 7, 2024 PLCO-1586
Examining the Influence of Racial/Ethnic Disparities and Comorbidities on Survival Rates in Pancreatic Cancer Patients Ashley Renning University of Delaware PLCO Jun 7, 2024 PLCO-1587